Global Renal Denervation (RDN) System Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Renal Denervation (RDN) System market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Renal Denervation (RDN) is a percutaneous interventional treatment method. It mainly uses energy such as radio frequency and ultrasound to eliminate the afferent and efferent nerves in the renal artery, blocking the signal conduction between the brain and sympathetic nerves to a certain extent, thereby reducing the risk of high blood pressure. The sympathetic nerve excitability of patients with high blood pressure can achieve long-term and stable blood pressure lowering effects with one minimally invasive surgery.
Currently, the typical models of Renal Denervation (RDN) System include Recor Medical’s Paradise and Medtronic’s Simplicity Spyral, etc.
This report is a detailed and comprehensive analysis for global Renal Denervation (RDN) System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Renal Denervation (RDN) System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Renal Denervation (RDN) System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Renal Denervation (RDN) System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Renal Denervation (RDN) System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Renal Denervation (RDN) System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Renal Denervation (RDN) System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Recor Medical, Boston Scientific, Cardiosonic, Shanghai Bioheart, Shanghai Golden Leaf, Suzhou SyMap, MicroPort, Cryofocus Medtech, Shanghai Hantong, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Renal Denervation (RDN) System market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Radiofrequency Ablation
Ultrasound Ablation
Others
Market segment by Application
High Blood Pressure Treatment
Others
Major players covered
Medtronic
Recor Medical
Boston Scientific
Cardiosonic
Shanghai Bioheart
Shanghai Golden Leaf
Suzhou SyMap
MicroPort
Cryofocus Medtech
Shanghai Hantong
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Renal Denervation (RDN) System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Renal Denervation (RDN) System, with price, sales quantity, revenue, and global market share of Renal Denervation (RDN) System from 2020 to 2025.
Chapter 3, the Renal Denervation (RDN) System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Renal Denervation (RDN) System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Renal Denervation (RDN) System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Renal Denervation (RDN) System.
Chapter 14 and 15, to describe Renal Denervation (RDN) System sales channel, distributors, customers, research findings and conclusion.
Renal Denervation (RDN) is a percutaneous interventional treatment method. It mainly uses energy such as radio frequency and ultrasound to eliminate the afferent and efferent nerves in the renal artery, blocking the signal conduction between the brain and sympathetic nerves to a certain extent, thereby reducing the risk of high blood pressure. The sympathetic nerve excitability of patients with high blood pressure can achieve long-term and stable blood pressure lowering effects with one minimally invasive surgery.
Currently, the typical models of Renal Denervation (RDN) System include Recor Medical’s Paradise and Medtronic’s Simplicity Spyral, etc.
This report is a detailed and comprehensive analysis for global Renal Denervation (RDN) System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Renal Denervation (RDN) System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Renal Denervation (RDN) System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Renal Denervation (RDN) System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Renal Denervation (RDN) System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Renal Denervation (RDN) System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Renal Denervation (RDN) System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Recor Medical, Boston Scientific, Cardiosonic, Shanghai Bioheart, Shanghai Golden Leaf, Suzhou SyMap, MicroPort, Cryofocus Medtech, Shanghai Hantong, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Renal Denervation (RDN) System market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Radiofrequency Ablation
Ultrasound Ablation
Others
Market segment by Application
High Blood Pressure Treatment
Others
Major players covered
Medtronic
Recor Medical
Boston Scientific
Cardiosonic
Shanghai Bioheart
Shanghai Golden Leaf
Suzhou SyMap
MicroPort
Cryofocus Medtech
Shanghai Hantong
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Renal Denervation (RDN) System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Renal Denervation (RDN) System, with price, sales quantity, revenue, and global market share of Renal Denervation (RDN) System from 2020 to 2025.
Chapter 3, the Renal Denervation (RDN) System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Renal Denervation (RDN) System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Renal Denervation (RDN) System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Renal Denervation (RDN) System.
Chapter 14 and 15, to describe Renal Denervation (RDN) System sales channel, distributors, customers, research findings and conclusion.
Table of Contents
96 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Renal Denervation (RDN) System by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
